Hook & Thesis
Service Corporation International (SCI) is the kind of business investors generally tolerate owning through cycles: steady, cash-generative, and with pricing power in inelastic end markets. The stock has pulled back into the low $70s after modest Q3 misses and a lowered full-year EPS guide. That pullback offers a favorable risk-reward for an opportunistic buyer who believes the long-term economics of deathcare remain intact and who is willing to accept modest leverage-related risk while waiting for sentiment to recover.
The trade here is straightforward: buy SCI at $73.47 with a tight stop under the recent 52-week low and targets that reflect both multiple re-rating and a recovery toward the prior 52-week high. The business is not wildly cheap on headline multiples - P/E sits around 18.8 and price-to-book is elevated - but free cash flow of roughly $584 million on a sub-$10 billion market cap supports a mid-single-digit FCF yield and a sustainable dividend (current yield ~1.85%). For investors looking for a defensive, cash-yielding position, SCI is a defensible buy at these levels.
What SCI Does and Why the Market Should Care
SCI is North America's largest deathcare provider, operating through Funeral and Cemetery segments. The funeral business covers traditional services, cremations and related offerings; the cemetery business sells interment rights (lawn crypts, mausoleum spaces, niches). Demand is relatively inelastic, giving SCI pricing power and steady revenue even when volumes fluctuate. That combination - recurring revenue, strong pricing mix in cemeteries (higher-margin, deferred revenue preneed) and scale - creates a resilient cash flow profile investors prize in defensive allocations.
Why care now? The market sold off SCI after a quarter that came in a touch light versus expectations and after management trimmed full-year adjusted EPS guidance to $3.94 - $4.04 from $4.10 - $4.30. That guidance reset is why the price sits nearer the 52-week low ($68.41). But operating cash flow guidance was reaffirmed and free cash flow remains healthy at about $584 million. For long-term investors, stability in cash conversion and a history of dividend increases argue for buying weakness rather than exiting.
Key Fundamental Data (select figures)
- Current price: $73.47
- Market cap: about $9.99 billion
- Q3 2026 revenue: $1.11 billion (up ~4.7% year-over-year)
- Q3 2026 adjusted EPS: $0.97 (missed estimates slightly)
- Full-year adjusted EPS guidance: $3.94 - $4.04 (lowered)
- Free cash flow (trailing/annualized): $584,069,000
- P/E: ~18.8; EV/EBITDA: 11.4
- Debt-to-equity: 3.28 (financial leverage is meaningful)
- Dividend per share: $0.36 quarterly; yield about 1.85%
How the Q3 Print Affects the Setup
On 10/29/2026 SCI reported Q3 adjusted EPS of $0.97 and $1.11 billion of revenue, both slightly below consensus. Management reduced full-year adjusted EPS guidance to $3.94 - $4.04, citing softer funeral volumes and cost pressure, though they reaffirmed operating cash flow guidance. Those are not trivial signals, but they do not materially change the core thesis: SCI earns high-quality cash in a business with pricing levers (service price increases, cemetery product sales and preneed growth).
Valuation Framing
At a market cap just under $10 billion and free cash flow near $584 million, SCI trades with an implied FCF yield in the mid-single digits. Headline multiples - P/E ~18.8 and EV/EBITDA ~11.4 - are not bargain basement, but they are reasonable for a high-ROE business (ROE ~35.6%). The valuation sits closer to the low end of the stock's 52-week range (52-week high $90.99, low $68.41), giving buyers the chance to add quality at a modest discount to recent peaks. The key caveat is leverage: debt-to-equity near 3.28 elevates balance-sheet sensitivity to rates, so the market will rightly apply a premium for visible cash conversion and steady margins.
Catalysts (what could lift the stock)
- Stabilizing funeral volumes and higher service mix: improving volumes would close the earnings gap to previous guidance and restore growth credibility.
- Operational cost control and margin recovery: any signs of falling unit costs or improved cemetery margins could drive upside to operating leverage.
- Share repurchase activity or dividend increases: management has a history of returning capital; renewed buybacks would signal confidence and tighten shares outstanding.
- Positive preneed sales trends: durable growth in preneed sales supports long-term revenue visibility for cemetery units.
- Multiple re-rating after consensus earnings stabilization: if the market sees EPS around the $4.00 level as sustainable, a modest multiple expansion could add meaningful upside.
Actionable Trade Plan
- Direction: Long
- Entry price: $73.47
- Stop loss: $68.00 (placed below the 52-week low to avoid normal noise)
- Target 1: $85.00 (mid-term target reflecting partial recovery and multiple re-rating)
- Target 2: $92.00 (ambitious target near the 52-week high if fundamentals re-accelerate)
- Horizon: long term (180 trading days) — this trade assumes 4-6 quarters for volumes and margins to normalize and for sentiment around guidance to improve.
Rationale: Target 1 captures roughly 15.7% upside to $85.00 and is realistic if EPS stabilizes near the upper end of the revised guidance and the multiple creeps modestly higher. Target 2 is a stretch target that assumes both operational improvement and market multiple recovery toward the prior 52-week peak.
Risk and Counterarguments
SCI is not without material risks. Below are the principal ones to watch, followed by the counterargument to the bullish case.
Key risks
- Leverage and interest-rate sensitivity: debt-to-equity around 3.28 means higher rates or weaker cash flow could pressure the balance sheet and constrain buybacks/dividends.
- Structural mix shift toward cremation: rising cremation penetration tends to depress per-service revenue and could weigh on margins over time.
- Volume softness persists: if funeral volumes stay weak longer than management expects, EPS could undershoot even the revised guide.
- Competition and pricing pressure in local markets: SCI’s local-market advantages are real, but aggressive pricing or regional competitors could erode share.
- Regulatory or reputational shocks: as a provider of sensitive services, operational lapses or local regulatory changes could have outsized earnings impact.
Counterargument
The bear case has teeth: a prolonged decline in funeral volumes combined with sustained margin pressure and rising interest costs could make SCI’s current multiple look too optimistic. If free cash flow weakens materially, the dividend and buyback story evaporates and the multiple could compress further. For investors who prioritize balance-sheet conservatism, SCI’s leverage is a legitimate deterrent to a large position.
However, the counter to that counterargument is that SCI’s business is cash-rich and historically resilient. Even with softer volumes, the cemetery business and preneed sales provide revenue that is less cyclically sensitive. Management's choice to reaffirm operating cash flow guidance is a signal that the cash engine is holding up despite pressure on near-term EPS.
What Would Change My Mind
I will reassess my view if any of the following occur:
- Management revises operating cash flow guidance downward or reports meaningful deterioration in cash conversion metrics.
- Net leverage moves meaningfully higher (sustained increase in debt or material drop in equity), reducing financial flexibility.
- Persistent, accelerating declines in preneed sales or cemetery unit volumes indicating structural demand weakness.
- A sustained failure to restore margins despite cost initiatives, implying secular margin erosion rather than temporary pressure.
Conclusion
SCI is a high-quality, cash-generative business trading at a fair-but-not-cheap multiple. The recent dip after a guidance cut is a compensating opportunity: free cash flow remains strong, dividend policy is intact and the underlying demand profile is inelastic. For investors comfortable with the leverage profile and the sector dynamics, buying at $73.47 with a stop at $68.00 and targets at $85 and $92 represents a disciplined way to capture upside while controlling downside. The principal things to monitor are cash flow resilience, leverage, and whether funeral volume trends stabilize. If those items check out, the stock should reward patient holders over the next 180 trading days.